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One hundred sixty-three patients with mild to moderate mitral regurgitation and 326 patients
without mitral regurgitation underwent isolated CABG. Mitral regurgitation was associated with
poorer event-free survival and worse NYHA functional class. By multivariable adjustment,
mitral regurgitation was a significant predictor of late events and poorer event-free survival.
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Valve repair was performed in 160 patients who had aortic valve regurgitation. Early risk of
death was 0.6%, and the cumulative risk of reoperation for aortic valve replacement was 11% 5
years postoperatively.
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In an experimental model of chronic ischemic mitral regurgitation (CIMR), septal-lateral
annular cinching reduced CIMR and maintained normal annular and leaflet dynamics. These
findings provide additional insight in the treatment of CIMR as surgeons search for ways to
restore normal function to the leaking but morphologically normal valve.
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Between 1992 and 1997, 103 patients underwent repair of descending thoracic aortic aneurysms
using first-generation stent grafts. Survival was 78%  6% at 5 years in open surgical
candidates, but those judged inoperable fared very poorly (31%  6% survival). Actuarial
freedom from aortic reintervention and treatment failure at 8 years were 70%  6% and 39%
 8%, respectively.
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Recurrent 3 to 4 regurgitation is common after tricuspid valve annuloplasty for functional
tricuspid regurgitation. It occurs more often with De Vega or Peri-Guard annuloplasties,
permanent pacemakers, left ventricular dysfunction, and higher preoperative tricuspid
regurgitation grade. Peri-Guard and De Vega annuloplasty should be abandoned and
transtricuspid leads replaced by epicardial leads.
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